Finance News – Pharma
What is your interest today?
Bitcoin
Crypto
Btc
Ceo
Stocks
Investors
Tariffs
Shares
Stock
Stock Market
Crypto Assets
Cryptocurrency
Ethereum
Price
Markets
Xrp
Stablecoin
Investment
Etf
Blockchain
Bse
Ipo
Eth
Sec
Index
Solana
Trade
Inflation
Earnings
Coinbase
Interest Rates
Revenue
Token
Sensex
Wall Street
China
Nasdaq
Federal Reserve
Treasury
Nse
Traders
Bse Sensex
Gold
Sp 500
Nifty
Tesla
Economy
Usd
Profit
Investor
Sec Filings
Gensol Engineering
Coti
Crypto Law Reforms
Series A Funding
Nhs Staff
Economic Rate
Privacy Standards
Investment Structures
Bidding Rules
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Business Insider Markets • Jun 03, 2025
Kamari Pharma Announces Closing of $23 Million Financing to Advance its First-In-Class Oral TRPV3 In...
Kamari Pharma secured $23 million in funding led by BRM Group and Pontifax to support the clinical development of its novel oral TRPV3 inhibitor targeting rare genetic skin conditi...
Read Full Article →
Quartz • May 30, 2025
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race
Despite its initial leadership in the growing weight loss medication sector, Novo Nordisk has recently experienced a decline in market share compared to Eli Lilly, affecting its fi...
Read Full Article →
Quartz • May 12, 2025
Eli Lilly stock sinks as pharma misses out on the market rally
Eli Lilly experienced a notable decline in share value as broader pharmaceutical stocks failed to benefit from the market’s upward movement, influenced by new government policies o...
Read Full Article →